Tamoxifen for the Prevention of Breast Cancer: Late Results of the Italian Randomized Tamoxifen Prevention Trial Among Women With Hysterectomy
Umberto Veronesi(Fondazione IRCCS Istituto Nazionale dei Tumori), Andrea DeCensi(Memorial Sloan Kettering Cancer Center), Peter Boyle(ZHAW Zurich University of Applied Sciences), Patrick Maisonneuve(European Institute of Oncology), Maria Grazia Muraca(Memorial Sloan Kettering Cancer Center), B. Bonanni(Memorial Sloan Kettering Cancer Center), Roberto Travaglini(Memorial Sloan Kettering Cancer Center), G Gucciardo(Memorial Sloan Kettering Cancer Center), P. Oliviero(Memorial Sloan Kettering Cancer Center), Giulia Viale(Istituti di Ricovero e Cura a Carattere Scientifico), Serena Conforti(Memorial Sloan Kettering Cancer Center), Maria Antonietta Pizzichetta(University of Trieste), Nicole Rotmensz(European Organisation for Research and Treatment of Cancer), A. Costa(Memorial Sloan Kettering Cancer Center), Giuseppe D’Aiuto(Memorial Sloan Kettering Cancer Center), Virgilio Sacchini(Memorial Sloan Kettering Cancer Center), Marco Rosselli Del Turco(Universidad de Murcia), F. Lovison(Memorial Sloan Kettering Cancer Center)
Cited by 242
Related Papers
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
|Cancer Epidemiology Biomarkers & Prevention|2005|2.2k
Hereditary Pancreatitis and the Risk of Pancreatic Cancer
|JNCI Journal of the National Cancer Institute|1997|986
Development and Validation of a Food Frequency Questionnaire in Spain
|International Journal of Epidemiology|1993|933
HER2-Low Breast Cancer: Pathological and Clinical Landscape
|Journal of Clinical Oncology|2020|801
Breast Cancer
|New England Journal of Medicine|1992|701